A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer

NCT02999477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Nab-Paclitaxel
PROCEDURE: Biopsy

Sponsor

Adrienne G. Waks

Collaborators

[object Object]